Related Experiment Video
Updated: Jul 8, 2025
03:57
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
1.9K
Robotic parathyroidectomy is a feasible technique for primary hyperparathyroidism
Jin Seok Lee1, Jun Sung Lee1, Hojung Jeong1
1Department of Surgery, Thyroid Cancer Center, Institute of Refractory Thyroid Cancer, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonjuro, Gangnam-Gu, Seoul, 135-720, Korea.
Langenbeck'S Archives of Surgery
|December 16, 2023
Summary
Gasless robotic transaxillary parathyroidectomy is a safe and effective minimally invasive option for primary hyperparathyroidism, offering excellent cosmetic outcomes without neck scarring. This technique is feasible for select patients with preoperatively localized disease.
Area of Science:
- Endocrinology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Focused parathyroidectomy is the standard for primary hyperparathyroidism.
- Robotic surgery offers a minimally invasive approach for parathyroidectomy.
Purpose of the Study:
- To evaluate the feasibility and outcomes of gasless robotic transaxillary parathyroidectomy.
- To report single-center experiences with this technique for primary hyperparathyroidism.
Main Methods:
- Retrospective analysis of 12 patients with primary hyperparathyroidism.
- Patients underwent gasless robotic transaxillary parathyroidectomy between December 2013 and August 2022.
- Data included clinical, biochemical, pathological features, and operative parameters.
Main Results:
- All 12 patients had parathyroid adenomas; 11 were female, median age 44.5 years.
- Median operative time was 113 minutes; one postoperative bleeding complication occurred.
- Post-surgery, axillary scars averaged 5.85 cm; no neck scarring was observed.
Conclusions:
- Gasless robotic transaxillary parathyroidectomy is a safe and feasible option for select patients.
- The approach provides excellent cosmetic results by avoiding neck incisions.
- This technique is suitable for primary hyperparathyroidism with preoperatively localized disease.
